Their own payment-practices filing · gov.uk
Ipsen Biopharm Limited pays suppliers in 31 days on average — within its stated 30–60 day terms
Their H1 2026 filing puts the average 1 day past the shortest term they state (30 days), still within their 60-day upper term.
- Their stated terms
- 30–60 days
- Paid outside agreed terms
- 28% of invoices
- Paid after 61+ days
- 7%
- Reporting period
- 1 Jan 2026 – 30 Jun 2026
- Source
- their gov.uk filing, filed 28 Jul 2026
Self-reported figures from their statutory filing. How this is compiled.
Terms vs reality · their H1 2026 filing
Paid within their stated range — 31 against 30–60 days
Where their invoices landed · share of all invoices
The pattern · last 6 of 17 reports
Holding steady around 31 days
The read · computed from their figures
Ipsen Biopharm Limited's H1 2026 filing puts their average at 31 days against stated terms of 30–60 days; 28% of invoices were paid outside agreed terms and 7% took 61 days or longer. Filed 28 Jul 2026.
The pattern is steady — their reported average moves within about ±4 days period to period.
On the latest reported averages: Faster than 84% of the 977 large companies reporting in manufacturing.
That is 17 statutory periods on record (earliest H1 2018) — a historical record, not a promise for a new invoice.
In their own words · from the filing
Standard payment terms
Standard payment terms: 30 days from the invoice date for historical third-party vendors. 60 days from the invoice date for new vendor creations. 45days end of the month for intercompany transactions. Any changes – answer no
Dispute resolution
In case of any discrepancy between goods received and invoice receipt - person who made an order is responsible for contacting the vendor and understand the difference There is a generic email address and direct phone number available for all vendors where all payment related questions can be routed Terms and conditions are attached to the copy of the Purchase Order that is sent to vendors
Every statutory report on record
Most recent first.
| Period | Avg days | Outside terms | 61+ days | Filed |
|---|---|---|---|---|
| H1 2026 | 31 | 28% | 7% | 28 Jul 2026 |
| H2 2025 | 28 | 26% | 5% | 22 Jan 2026 |
| H1 2025 | 34 | 23% | 9% | 30 Jul 2025 |
| H2 2024 | 35 | 23% | 10% | 28 Jan 2025 |
| H1 2024 | 32 | 21% | 9% | 31 Jul 2024 |
| H2 2023 | 32 | 22% | 10% | 30 Jan 2024 |
| H1 2023 | 30 | 29% | 6% | 31 Jul 2023 |
| H2 2022 | 30 | 28% | 5% | 25 Jan 2023 |
| H1 2022 | 32 | 22% | 8% | 21 Jul 2022 |
| H2 2021 | 29 | 19% | 4% | 25 Jan 2022 |
| H1 2021 | 28 | 23% | 4% | 29 Jul 2021 |
| H2 2020 | 30 | 16% | 5% | 29 Jan 2021 |
| H1 2020 | 29 | 17% | 5% | 24 Jul 2020 |
| H2 2019 | 30 | 19% | 4% | 28 Jan 2020 |
| H1 2019 | 30 | 22% | 5% | 26 Jul 2019 |
| H2 2018 | 30 | 20% | 4% | 25 Jan 2019 |
| H1 2018 | 30 | 31% | 5% | 18 Jul 2018 |
On the public register · Companies House
Company record
- Status
- Active
- Type
- Private Limited Company
- Incorporated
- 23 Jul 1982
- Registered office
- ASH ROAD, WREXHAM, LL13 9UF
Quick answers · Ipsen Biopharm Limited
Are they getting slower or faster?
What's their typical pay point?
Can I see what this means for my invoices?
Stay ahead
Watch Ipsen Biopharm Limited (free)
Their next payment report is due ≈ 26 Jan 2027. We watch their public record and email you when something changes — a new payment report, late filings, insolvency markers, new charges.
You’ll get a confirmation email first. Unsubscribe any time. How we handle your address.
More large companies in manufacturing
Ipl Plastics (UK) Limited · Isg Retail Limited · Ipeco Holdings Limited · Ishida Europe Ltd. · Invista Textiles (U.K.) Limited · Islestarr Holdings Limited
How UK payment reporting works
What is a Payment Practices Report?
What does "paid outside agreed terms" mean?
How often is this data updated?
Is this official government data?
How this is compiled. Built from official records only: Companies House and the gov.uk payment-practices service. The payment figures are self-reported — companies over the size threshold must file them by law and the board signs them off. No credit-agency data. The numbers are theirs; the plain-English read is ours. This is information compiled from public records under the Open Government Licence v3.0 — not a credit rating and not advice.
The 31-day comparison figure is the median across 6,104 companies with a current statutory report — every sector pooled, not an average of sector medians (how the figure is built).
Report PL-01653765 · latest period to 30 Jun 2026
Built by YORXEN LTD · registered in England & Wales · CRN 17303256 · privacy · terms.